A new look at rheumatology in China--opportunities and challenges.
about
The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study.Brief report on academic contributions from China on the topic of rheumatic diseases.Salvianolic Acid B Suppresses Inflammatory Mediator Levels by Downregulating NF-κB in a Rat Model of Rheumatoid Arthritis.
P2860
A new look at rheumatology in China--opportunities and challenges.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A new look at rheumatology in China--opportunities and challenges.
@en
type
label
A new look at rheumatology in China--opportunities and challenges.
@en
prefLabel
A new look at rheumatology in China--opportunities and challenges.
@en
P2860
P356
P1476
A new look at rheumatology in China--opportunities and challenges.
@en
P2093
Zhan-Guo Li
P2860
P2888
P304
P356
10.1038/NRRHEUM.2014.218
P407
P577
2015-01-20T00:00:00Z
P6179
1020676288